APO Research
Talk to an analyst

APO RESEARCH · REPORT

SPECT and PET Radiopharmaceuticals

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global SPECT and PET Radiopharmaceuticals Industry Growth and Trends Forecast to 2032

23 December 2025102 pages

Choose your research edition.

Industry ResearchSPECT and PET Radiopharmaceuticals Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal SPECT and PET Radiopharmaceuticals Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal SPECT and PET Radiopharmaceuticals Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal SPECT and PET Radiopharmaceuticals Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal SPECT and PET Radiopharmaceuticals Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global SPECT and PET Radiopharmaceuticals market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for SPECT and PET Radiopharmaceuticals is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for SPECT and PET Radiopharmaceuticals is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for SPECT and PET Radiopharmaceuticals is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of SPECT and PET Radiopharmaceuticals include China Isotope & Radiation, Novartis, Eli Lilly, Dongcheng, Bayer, SIEMENS, Mundipharma, Lantheus and Jubilant Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global SPECT and PET Radiopharmaceuticals market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The SPECT and PET Radiopharmaceuticals market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global SPECT and PET Radiopharmaceuticals market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to SPECT and PET Radiopharmaceuticals.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global SPECT and PET Radiopharmaceuticals market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

SPECT and PET Radiopharmaceuticals Market by Company

China Isotope & Radiation

Novartis

Eli Lilly

Dongcheng

Bayer

SIEMENS

Mundipharma

Lantheus

Jubilant Pharma

GE Healthcare

Curium Pharma

Cardinal Health

Bracco Imaging

Aurobindo Pharma

SPECT and PET Radiopharmaceuticals Segment by Type

Diagnostic Radiopharmaceuticals

Therapeutic Radiopharmaceuticals

SPECT and PET Radiopharmaceuticals Segment by Application

Hospitals

Clinics

Others

SPECT and PET Radiopharmaceuticals Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global SPECT and PET Radiopharmaceuticals market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of SPECT and PET Radiopharmaceuticals and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of SPECT and PET Radiopharmaceuticals.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of SPECT and PET Radiopharmaceuticals manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of SPECT and PET Radiopharmaceuticals in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Diagnostic Radiopharmaceuticals Table 2. Major Company of Therapeutic Radiopharmaceuticals Table 3. Global SPECT and PET Radiopharmaceuticals Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global SPECT and PET Radiopharmaceuticals Sales by Type (2021-2026) & (k units) Table 5. Global SPECT and PET Radiopharmaceuticals Sales Market Share in Volume by Type (2021-2026) Table 6. Global SPECT and PET Radiopharmaceuticals Sales by Type (2021-2026) & (US$ Million) Table 7. Global SPECT and PET Radiopharmaceuticals Sales Market Share in Value by Type (2021-2026) Table 8. Global SPECT and PET Radiopharmaceuticals Price by Type (2021-2026) & (USD/unit) Table 9. Global SPECT and PET Radiopharmaceuticals Sales by Type (2027-2032) & (k units) Table 10. Global SPECT and PET Radiopharmaceuticals Sales Market Share in Volume by Type (2027-2032) Table 11. Global SPECT and PET Radiopharmaceuticals Sales by Type (2027-2032) & (US$ Million) Table 12. Global SPECT and PET Radiopharmaceuticals Sales Market Share in Value by Type (2027-2032) Table 13. Global SPECT and PET Radiopharmaceuticals Price by Type (2027-2032) & (USD/unit) Table 14. North America SPECT and PET Radiopharmaceuticals Sales by Type (2021-2026) & (k units) Table 15. North America SPECT and PET Radiopharmaceuticals Sales by Type (2021-2026) & (US$ Million) Table 16. Europe SPECT and PET Radiopharmaceuticals Sales by Type (2021-2026) & (k units) Table 17. Europe SPECT and PET Radiopharmaceuticals Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific SPECT and PET Radiopharmaceuticals Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific SPECT and PET Radiopharmaceuticals Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America SPECT and PET Radiopharmaceuticals Sales by Type (2021-2026) & (k units) Table 21. Latin America SPECT and PET Radiopharmaceuticals Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa SPECT and PET Radiopharmaceuticals Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa SPECT and PET Radiopharmaceuticals Sales by Type (2021-2026) & (US$ Million) Table 24. SPECT and PET Radiopharmaceuticals Industry Trends Table 25. SPECT and PET Radiopharmaceuticals Industry Drivers Table 26. SPECT and PET Radiopharmaceuticals Industry Opportunities and Challenges Table 27. SPECT and PET Radiopharmaceuticals Industry Restraints Table 28. Global SPECT and PET Radiopharmaceuticals Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global SPECT and PET Radiopharmaceuticals Revenue Market Share by Company (2021-2026) Table 30. Global SPECT and PET Radiopharmaceuticals Sales by Company (2021-2026) & (k units) Table 31. Global SPECT and PET Radiopharmaceuticals Sales Share by Company (2021-2026) Table 32. Global SPECT and PET Radiopharmaceuticals Market Price by Company (2021-2026) & (USD/unit) Table 33. Global SPECT and PET Radiopharmaceuticals Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global SPECT and PET Radiopharmaceuticals Major Company Production Sites and Headquarters Table 35. Global SPECT and PET Radiopharmaceuticals Company, Product Type & Application Table 36. Global SPECT and PET Radiopharmaceuticals Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global SPECT and PET Radiopharmaceuticals by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global SPECT and PET Radiopharmaceuticals Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global SPECT and PET Radiopharmaceuticals Sales by Region (2021-2026) & (k units) Table 41. Global SPECT and PET Radiopharmaceuticals Sales Market Share in Volume by Region (2021-2026) Table 42. Global SPECT and PET Radiopharmaceuticals Sales by Region (2021-2026) & (US$ Million) Table 43. Global SPECT and PET Radiopharmaceuticals Sales Market Share in Value by Region (2021-2026) Table 44. Global SPECT and PET Radiopharmaceuticals Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 45. Global SPECT and PET Radiopharmaceuticals Sales by Region (2027-2032) & (k units) Table 46. Global SPECT and PET Radiopharmaceuticals Sales Market Share in Volume by Region (2027-2032) Table 47. Global SPECT and PET Radiopharmaceuticals Sales by Region (2027-2032) & (US$ Million) Table 48. Global SPECT and PET Radiopharmaceuticals Sales Market Share in Value by Region (2027-2032) Table 49. Global SPECT and PET Radiopharmaceuticals Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2027-2032) Table 50. Global SPECT and PET Radiopharmaceuticals Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global SPECT and PET Radiopharmaceuticals Sales by Application (2021-2026) & (k units) Table 52. Global SPECT and PET Radiopharmaceuticals Sales Market Share in Volume by Application (2021-2026) Table 53. Global SPECT and PET Radiopharmaceuticals Sales by Application (2021-2026) & (US$ Million) Table 54. Global SPECT and PET Radiopharmaceuticals Sales Market Share in Value by Application (2021-2026) Table 55. Global SPECT and PET Radiopharmaceuticals Price by Application (2021-2026) & (USD/unit) Table 56. Global SPECT and PET Radiopharmaceuticals Sales by Application (2027-2032) & (k units) Table 57. Global SPECT and PET Radiopharmaceuticals Sales Market Share in Volume by Application (2027-2032) Table 58. Global SPECT and PET Radiopharmaceuticals Sales by Application (2027-2032) & (US$ Million) Table 59. Global SPECT and PET Radiopharmaceuticals Sales Market Share in Value by Application (2027-2032) Table 60. Global SPECT and PET Radiopharmaceuticals Price by Application (2027-2032) & (USD/unit) Table 61. North America SPECT and PET Radiopharmaceuticals Sales by Application (2021-2026) & (k units) Table 62. North America SPECT and PET Radiopharmaceuticals Sales by Application (2021-2026) & (US$ Million) Table 63. Europe SPECT and PET Radiopharmaceuticals Sales by Application (2021-2026) & (k units) Table 64. Europe SPECT and PET Radiopharmaceuticals Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific SPECT and PET Radiopharmaceuticals Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific SPECT and PET Radiopharmaceuticals Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America SPECT and PET Radiopharmaceuticals Sales by Application (2021-2026) & (k units) Table 68. Latin America SPECT and PET Radiopharmaceuticals Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa SPECT and PET Radiopharmaceuticals Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa SPECT and PET Radiopharmaceuticals Sales by Application (2021-2026) & (US$ Million) Table 71. China Isotope & Radiation Company Information Table 72. China Isotope & Radiation Business Overview Table 73. China Isotope & Radiation SPECT and PET Radiopharmaceuticals Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 74. China Isotope & Radiation SPECT and PET Radiopharmaceuticals Product Portfolio Table 75. China Isotope & Radiation Recent Development Table 76. Novartis Company Information Table 77. Novartis Business Overview Table 78. Novartis SPECT and PET Radiopharmaceuticals Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 79. Novartis SPECT and PET Radiopharmaceuticals Product Portfolio Table 80. Novartis Recent Development Table 81. Eli Lilly Company Information Table 82. Eli Lilly Business Overview Table 83. Eli Lilly SPECT and PET Radiopharmaceuticals Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 84. Eli Lilly SPECT and PET Radiopharmaceuticals Product Portfolio Table 85. Eli Lilly Recent Development Table 86. Dongcheng Company Information Table 87. Dongcheng Business Overview Table 88. Dongcheng SPECT and PET Radiopharmaceuticals Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 89. Dongcheng SPECT and PET Radiopharmaceuticals Product Portfolio Table 90. Dongcheng Recent Development Table 91. Bayer Company Information Table 92. Bayer Business Overview Table 93. Bayer SPECT and PET Radiopharmaceuticals Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Bayer SPECT and PET Radiopharmaceuticals Product Portfolio Table 95. Bayer Recent Development Table 96. SIEMENS Company Information Table 97. SIEMENS Business Overview Table 98. SIEMENS SPECT and PET Radiopharmaceuticals Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. SIEMENS SPECT and PET Radiopharmaceuticals Product Portfolio Table 100. SIEMENS Recent Development Table 101. Mundipharma Company Information Table 102. Mundipharma Business Overview Table 103. Mundipharma SPECT and PET Radiopharmaceuticals Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. Mundipharma SPECT and PET Radiopharmaceuticals Product Portfolio Table 105. Mundipharma Recent Development Table 106. Lantheus Company Information Table 107. Lantheus Business Overview Table 108. Lantheus SPECT and PET Radiopharmaceuticals Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. Lantheus SPECT and PET Radiopharmaceuticals Product Portfolio Table 110. Lantheus Recent Development Table 111. Jubilant Pharma Company Information Table 112. Jubilant Pharma Business Overview Table 113. Jubilant Pharma SPECT and PET Radiopharmaceuticals Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 114. Jubilant Pharma SPECT and PET Radiopharmaceuticals Product Portfolio Table 115. Jubilant Pharma Recent Development Table 116. GE Healthcare Company Information Table 117. GE Healthcare Business Overview Table 118. GE Healthcare SPECT and PET Radiopharmaceuticals Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 119. GE Healthcare SPECT and PET Radiopharmaceuticals Product Portfolio Table 120. GE Healthcare Recent Development Table 121. Curium Pharma Company Information Table 122. Curium Pharma Business Overview Table 123. Curium Pharma SPECT and PET Radiopharmaceuticals Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 124. Curium Pharma SPECT and PET Radiopharmaceuticals Product Portfolio Table 125. Curium Pharma Recent Development Table 126. Cardinal Health Company Information Table 127. Cardinal Health Business Overview Table 128. Cardinal Health SPECT and PET Radiopharmaceuticals Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 129. Cardinal Health SPECT and PET Radiopharmaceuticals Product Portfolio Table 130. Cardinal Health Recent Development Table 131. Bracco Imaging Company Information Table 132. Bracco Imaging Business Overview Table 133. Bracco Imaging SPECT and PET Radiopharmaceuticals Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 134. Bracco Imaging SPECT and PET Radiopharmaceuticals Product Portfolio Table 135. Bracco Imaging Recent Development Table 136. Aurobindo Pharma Company Information Table 137. Aurobindo Pharma Business Overview Table 138. Aurobindo Pharma SPECT and PET Radiopharmaceuticals Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 139. Aurobindo Pharma SPECT and PET Radiopharmaceuticals Product Portfolio Table 140. Aurobindo Pharma Recent Development Table 141. North America SPECT and PET Radiopharmaceuticals Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 142. North America SPECT and PET Radiopharmaceuticals Sales by Country (2021-2026) & (k units) Table 143. North America SPECT and PET Radiopharmaceuticals Sales Market Share by Country (2021-2026) Table 144. North America SPECT and PET Radiopharmaceuticals Sales Forecast by Country (2027-2032) & (k units) Table 145. North America SPECT and PET Radiopharmaceuticals Sales Market Share Forecast by Country (2027-2032) Table 146. North America SPECT and PET Radiopharmaceuticals Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. North America SPECT and PET Radiopharmaceuticals Market Size by Country (2021-2026) & (US$ Million) Table 148. North America SPECT and PET Radiopharmaceuticals Market Share by Country (2021-2026) Table 149. North America SPECT and PET Radiopharmaceuticals Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. North America SPECT and PET Radiopharmaceuticals Market Share Forecast by Country (2027-2032) Table 151. Europe SPECT and PET Radiopharmaceuticals Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 152. Europe SPECT and PET Radiopharmaceuticals Sales by Country (2021-2026) & (k units) Table 153. Europe SPECT and PET Radiopharmaceuticals Sales Market Share by Country (2021-2026) Table 154. Europe SPECT and PET Radiopharmaceuticals Sales Forecast by Country (2027-2032) & (k units) Table 155. Europe SPECT and PET Radiopharmaceuticals Sales Market Share Forecast by Country (2027-2032) Table 156. Europe SPECT and PET Radiopharmaceuticals Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Europe SPECT and PET Radiopharmaceuticals Market Size by Country (2021-2026) & (US$ Million) Table 158. Europe SPECT and PET Radiopharmaceuticals Market Share by Country (2021-2026) Table 159. Europe SPECT and PET Radiopharmaceuticals Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Europe SPECT and PET Radiopharmaceuticals Market Share Forecast by Country (2027-2032) Table 161. Asia-Pacific SPECT and PET Radiopharmaceuticals Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 162. Asia-Pacific SPECT and PET Radiopharmaceuticals Sales by Country (2021-2026) & (k units) Table 163. Asia-Pacific SPECT and PET Radiopharmaceuticals Sales Market Share by Country (2021-2026) Table 164. Asia-Pacific SPECT and PET Radiopharmaceuticals Sales Forecast by Country (2027-2032) & (k units) Table 165. Asia-Pacific SPECT and PET Radiopharmaceuticals Sales Market Share Forecast by Country (2027-2032) Table 166. Asia-Pacific SPECT and PET Radiopharmaceuticals Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Asia-Pacific SPECT and PET Radiopharmaceuticals Market Size by Country (2021-2026) & (US$ Million) Table 168. Asia-Pacific SPECT and PET Radiopharmaceuticals Market Share by Country (2021-2026) Table 169. Asia-Pacific SPECT and PET Radiopharmaceuticals Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Asia-Pacific SPECT and PET Radiopharmaceuticals Market Share Forecast by Country (2027-2032) Table 171. Latin America SPECT and PET Radiopharmaceuticals Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 172. Latin America SPECT and PET Radiopharmaceuticals Sales by Country (2021-2026) & (k units) Table 173. Latin America SPECT and PET Radiopharmaceuticals Sales Market Share by Country (2021-2026) Table 174. Latin America SPECT and PET Radiopharmaceuticals Sales Forecast by Country (2027-2032) & (k units) Table 175. Latin America SPECT and PET Radiopharmaceuticals Sales Market Share Forecast by Country (2027-2032) Table 176. Latin America SPECT and PET Radiopharmaceuticals Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 177. Latin America SPECT and PET Radiopharmaceuticals Market Size by Country (2021-2026) & (US$ Million) Table 178. Latin America SPECT and PET Radiopharmaceuticals Market Share by Country (2021-2026) Table 179. Latin America SPECT and PET Radiopharmaceuticals Market Size Forecast by Country (2027-2032) & (US$ Million) Table 180. Latin America SPECT and PET Radiopharmaceuticals Market Share Forecast by Country (2027-2032) Table 181. Middle East and Africa SPECT and PET Radiopharmaceuticals Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 182. Middle East and Africa SPECT and PET Radiopharmaceuticals Sales by Country (2021-2026) & (k units) Table 183. Middle East and Africa SPECT and PET Radiopharmaceuticals Sales Market Share by Country (2021-2026) Table 184. Middle East and Africa SPECT and PET Radiopharmaceuticals Sales Forecast by Country (2027-2032) & (k units) Table 185. Middle East and Africa SPECT and PET Radiopharmaceuticals Sales Market Share Forecast by Country (2027-2032) Table 186. Middle East and Africa SPECT and PET Radiopharmaceuticals Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 187. Middle East and Africa SPECT and PET Radiopharmaceuticals Market Size by Country (2021-2026) & (US$ Million) Table 188. Middle East and Africa SPECT and PET Radiopharmaceuticals Market Share by Country (2021-2026) Table 189. Middle East and Africa SPECT and PET Radiopharmaceuticals Market Size Forecast by Country (2027-2032) & (US$ Million) Table 190. Middle East and Africa SPECT and PET Radiopharmaceuticals Market Share Forecast by Country (2027-2032) Table 191. Key Raw Materials Table 192. Raw Materials Key Suppliers Table 193. SPECT and PET Radiopharmaceuticals Distributors List Table 194. SPECT and PET Radiopharmaceuticals Customers List Table 195. Research Programs/Design for This Report Table 196. Authors List of This Report Table 197. Secondary Sources Table 198. Primary Sources List of Figures Figure 1. SPECT and PET Radiopharmaceuticals Image Figure 2. Global SPECT and PET Radiopharmaceuticals Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global SPECT and PET Radiopharmaceuticals Market Size (2021-2032) & (US$ Million) Figure 4. Global SPECT and PET Radiopharmaceuticals Sales (2021-2032) & (k units) Figure 5. Diagnostic Radiopharmaceuticals Image Figure 6. Global Diagnostic Radiopharmaceuticals Sales YoY Growth (2021-2032) & (k units) Figure 7. Therapeutic Radiopharmaceuticals Image Figure 8. Global Therapeutic Radiopharmaceuticals Sales YoY Growth (2021-2032) & (k units) Figure 9. Global SPECT and PET Radiopharmaceuticals Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global SPECT and PET Radiopharmaceuticals Market Share by Type 2025 VS 2032 Figure 11. North America SPECT and PET Radiopharmaceuticals Sales Market Share in Volume by Type in 2025 Figure 12. North America SPECT and PET Radiopharmaceuticals Sales Market Share in Value by Type in 2025 Figure 13. Europe SPECT and PET Radiopharmaceuticals Sales Market Share in Volume by Type in 2025 Figure 14. Europe SPECT and PET Radiopharmaceuticals Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific SPECT and PET Radiopharmaceuticals Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific SPECT and PET Radiopharmaceuticals Sales Market Share in Value by Type in 2025 Figure 17. Latin America SPECT and PET Radiopharmaceuticals Sales Market Share in Volume by Type in 2025 Figure 18. Latin America SPECT and PET Radiopharmaceuticals Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa SPECT and PET Radiopharmaceuticals Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa SPECT and PET Radiopharmaceuticals Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 SPECT and PET Radiopharmaceuticals Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospitals Image Figure 24. Global Hospitals Sales YoY Growth (2021-2032) & (k units) Figure 25. Clinics Image Figure 26. Global Clinics Sales YoY Growth (2021-2032) & (k units) Figure 27. Others Image Figure 28. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 29. Global SPECT and PET Radiopharmaceuticals Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global SPECT and PET Radiopharmaceuticals Market Share by Application 2025 VS 2032 Figure 31. North America SPECT and PET Radiopharmaceuticals Sales Market Share in Volume by Application in 2025 Figure 32. North America SPECT and PET Radiopharmaceuticals Sales Market Share in Value by Application in 2025 Figure 33. Europe SPECT and PET Radiopharmaceuticals Sales Market Share in Volume by Application in 2025 Figure 34. Europe SPECT and PET Radiopharmaceuticals Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific SPECT and PET Radiopharmaceuticals Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific SPECT and PET Radiopharmaceuticals Sales Market Share in Value by Application in 2025 Figure 37. Latin America SPECT and PET Radiopharmaceuticals Sales Market Share in Volume by Application in 2025 Figure 38. Latin America SPECT and PET Radiopharmaceuticals Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa SPECT and PET Radiopharmaceuticals Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa SPECT and PET Radiopharmaceuticals Sales Market Share in Value by Application in 2025 Figure 41. North America SPECT and PET Radiopharmaceuticals Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 42. North America SPECT and PET Radiopharmaceuticals Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America SPECT and PET Radiopharmaceuticals Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America SPECT and PET Radiopharmaceuticals Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe SPECT and PET Radiopharmaceuticals Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 46. Europe SPECT and PET Radiopharmaceuticals Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe SPECT and PET Radiopharmaceuticals Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe SPECT and PET Radiopharmaceuticals Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific SPECT and PET Radiopharmaceuticals Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. Asia-Pacific SPECT and PET Radiopharmaceuticals Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific SPECT and PET Radiopharmaceuticals Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific SPECT and PET Radiopharmaceuticals Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America SPECT and PET Radiopharmaceuticals Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Latin America SPECT and PET Radiopharmaceuticals Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America SPECT and PET Radiopharmaceuticals Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America SPECT and PET Radiopharmaceuticals Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa SPECT and PET Radiopharmaceuticals Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Middle East and Africa SPECT and PET Radiopharmaceuticals Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa SPECT and PET Radiopharmaceuticals Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa SPECT and PET Radiopharmaceuticals Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. SPECT and PET Radiopharmaceuticals Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. SPECT and PET Radiopharmaceuticals Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Diagnostic Radiopharmaceuticals
  • Therapeutic Radiopharmaceuticals
Applications
  • Hospitals
  • Clinics
  • Others
Companies covered
  • China Isotope & Radiation
  • Novartis
  • Eli Lilly
  • Dongcheng
  • Bayer
  • SIEMENS
  • Mundipharma
  • Lantheus
  • Jubilant Pharma
  • GE Healthcare
  • Curium Pharma
  • Cardinal Health
  • Bracco Imaging
  • Aurobindo Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global SPECT and PET Radiopharmaceuticals Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global SPECT and PET Radiopharmaceuticals Sales Estimates and Forecasts (2021-2032)
  5. 1.3 SPECT and PET Radiopharmaceuticals Market by Type
  6. 1.3.1 Diagnostic Radiopharmaceuticals
  7. 1.3.2 Therapeutic Radiopharmaceuticals
  8. 1.4 Global SPECT and PET Radiopharmaceuticals Market Size by Type
  9. 1.4.1 Global SPECT and PET Radiopharmaceuticals Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global SPECT and PET Radiopharmaceuticals Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global SPECT and PET Radiopharmaceuticals Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America SPECT and PET Radiopharmaceuticals Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe SPECT and PET Radiopharmaceuticals Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific SPECT and PET Radiopharmaceuticals Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America SPECT and PET Radiopharmaceuticals Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa SPECT and PET Radiopharmaceuticals Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 SPECT and PET Radiopharmaceuticals Industry Trends
  2. 2.2 SPECT and PET Radiopharmaceuticals Industry Drivers
  3. 2.3 SPECT and PET Radiopharmaceuticals Industry Opportunities and Challenges
  4. 2.4 SPECT and PET Radiopharmaceuticals Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by SPECT and PET Radiopharmaceuticals Revenue (2021-2026)
  2. 3.2 Global Top Players by SPECT and PET Radiopharmaceuticals Sales (2021-2026)
  3. 3.3 Global Top Players by SPECT and PET Radiopharmaceuticals Price (2021-2026)
  4. 3.4 Global SPECT and PET Radiopharmaceuticals Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global SPECT and PET Radiopharmaceuticals Major Company Production Sites & Headquarters
  6. 3.6 Global SPECT and PET Radiopharmaceuticals Company, Product Type & Application
  7. 3.7 Global SPECT and PET Radiopharmaceuticals Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global SPECT and PET Radiopharmaceuticals Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 SPECT and PET Radiopharmaceuticals Players Market Share by Revenue in 2025
  11. 3.8.3 2025 SPECT and PET Radiopharmaceuticals Tier 1, Tier 2, and Tier 3
4 SPECT and PET Radiopharmaceuticals Regional Status and Outlook
  1. 4.1 Global SPECT and PET Radiopharmaceuticals Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global SPECT and PET Radiopharmaceuticals Historic Market Size by Region
  3. 4.2.1 Global SPECT and PET Radiopharmaceuticals Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global SPECT and PET Radiopharmaceuticals Sales in Value by Region (2021-2026)
  5. 4.2.3 Global SPECT and PET Radiopharmaceuticals Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global SPECT and PET Radiopharmaceuticals Forecasted Market Size by Region
  7. 4.3.1 Global SPECT and PET Radiopharmaceuticals Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global SPECT and PET Radiopharmaceuticals Sales in Value by Region (2027-2032)
  9. 4.3.3 Global SPECT and PET Radiopharmaceuticals Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 SPECT and PET Radiopharmaceuticals by Application
  1. 5.1 SPECT and PET Radiopharmaceuticals Market by Application
  2. 5.1.1 Hospitals
  3. 5.1.2 Clinics
  4. 5.1.3 Others
  5. 5.2 Global SPECT and PET Radiopharmaceuticals Market Size by Application
  6. 5.2.1 Global SPECT and PET Radiopharmaceuticals Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global SPECT and PET Radiopharmaceuticals Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global SPECT and PET Radiopharmaceuticals Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America SPECT and PET Radiopharmaceuticals Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe SPECT and PET Radiopharmaceuticals Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific SPECT and PET Radiopharmaceuticals Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America SPECT and PET Radiopharmaceuticals Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa SPECT and PET Radiopharmaceuticals Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 China Isotope & Radiation
  2. 6.1.1 China Isotope & Radiation Company Information
  3. 6.1.2 China Isotope & Radiation Business Overview
  4. 6.1.3 China Isotope & Radiation SPECT and PET Radiopharmaceuticals Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 China Isotope & Radiation SPECT and PET Radiopharmaceuticals Product Portfolio
  6. 6.1.5 China Isotope & Radiation Recent Developments
  7. 6.2 Novartis
  8. 6.2.1 Novartis Company Information
  9. 6.2.2 Novartis Business Overview
  10. 6.2.3 Novartis SPECT and PET Radiopharmaceuticals Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Novartis SPECT and PET Radiopharmaceuticals Product Portfolio
  12. 6.2.5 Novartis Recent Developments
  13. 6.3 Eli Lilly
  14. 6.3.1 Eli Lilly Company Information
  15. 6.3.2 Eli Lilly Business Overview
  16. 6.3.3 Eli Lilly SPECT and PET Radiopharmaceuticals Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Eli Lilly SPECT and PET Radiopharmaceuticals Product Portfolio
  18. 6.3.5 Eli Lilly Recent Developments
  19. 6.4 Dongcheng
  20. 6.4.1 Dongcheng Company Information
  21. 6.4.2 Dongcheng Business Overview
  22. 6.4.3 Dongcheng SPECT and PET Radiopharmaceuticals Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Dongcheng SPECT and PET Radiopharmaceuticals Product Portfolio
  24. 6.4.5 Dongcheng Recent Developments
  25. 6.5 Bayer
  26. 6.5.1 Bayer Company Information
  27. 6.5.2 Bayer Business Overview
  28. 6.5.3 Bayer SPECT and PET Radiopharmaceuticals Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Bayer SPECT and PET Radiopharmaceuticals Product Portfolio
  30. 6.5.5 Bayer Recent Developments
  31. 6.6 SIEMENS
  32. 6.6.1 SIEMENS Company Information
  33. 6.6.2 SIEMENS Business Overview
  34. 6.6.3 SIEMENS SPECT and PET Radiopharmaceuticals Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 SIEMENS SPECT and PET Radiopharmaceuticals Product Portfolio
  36. 6.6.5 SIEMENS Recent Developments
  37. 6.7 Mundipharma
  38. 6.7.1 Mundipharma Company Information
  39. 6.7.2 Mundipharma Business Overview
  40. 6.7.3 Mundipharma SPECT and PET Radiopharmaceuticals Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Mundipharma SPECT and PET Radiopharmaceuticals Product Portfolio
  42. 6.7.5 Mundipharma Recent Developments
  43. 6.8 Lantheus
  44. 6.8.1 Lantheus Company Information
  45. 6.8.2 Lantheus Business Overview
  46. 6.8.3 Lantheus SPECT and PET Radiopharmaceuticals Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Lantheus SPECT and PET Radiopharmaceuticals Product Portfolio
  48. 6.8.5 Lantheus Recent Developments
  49. 6.9 Jubilant Pharma
  50. 6.9.1 Jubilant Pharma Company Information
  51. 6.9.2 Jubilant Pharma Business Overview
  52. 6.9.3 Jubilant Pharma SPECT and PET Radiopharmaceuticals Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Jubilant Pharma SPECT and PET Radiopharmaceuticals Product Portfolio
  54. 6.9.5 Jubilant Pharma Recent Developments
  55. 6.10 GE Healthcare
  56. 6.10.1 GE Healthcare Company Information
  57. 6.10.2 GE Healthcare Business Overview
  58. 6.10.3 GE Healthcare SPECT and PET Radiopharmaceuticals Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 GE Healthcare SPECT and PET Radiopharmaceuticals Product Portfolio
  60. 6.10.5 GE Healthcare Recent Developments
  61. 6.11 Curium Pharma
  62. 6.11.1 Curium Pharma Company Information
  63. 6.11.2 Curium Pharma Business Overview
  64. 6.11.3 Curium Pharma SPECT and PET Radiopharmaceuticals Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Curium Pharma SPECT and PET Radiopharmaceuticals Product Portfolio
  66. 6.11.5 Curium Pharma Recent Developments
  67. 6.12 Cardinal Health
  68. 6.12.1 Cardinal Health Company Information
  69. 6.12.2 Cardinal Health Business Overview
  70. 6.12.3 Cardinal Health SPECT and PET Radiopharmaceuticals Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Cardinal Health SPECT and PET Radiopharmaceuticals Product Portfolio
  72. 6.12.5 Cardinal Health Recent Developments
  73. 6.13 Bracco Imaging
  74. 6.13.1 Bracco Imaging Company Information
  75. 6.13.2 Bracco Imaging Business Overview
  76. 6.13.3 Bracco Imaging SPECT and PET Radiopharmaceuticals Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Bracco Imaging SPECT and PET Radiopharmaceuticals Product Portfolio
  78. 6.13.5 Bracco Imaging Recent Developments
  79. 6.14 Aurobindo Pharma
  80. 6.14.1 Aurobindo Pharma Company Information
  81. 6.14.2 Aurobindo Pharma Business Overview
  82. 6.14.3 Aurobindo Pharma SPECT and PET Radiopharmaceuticals Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Aurobindo Pharma SPECT and PET Radiopharmaceuticals Product Portfolio
  84. 6.14.5 Aurobindo Pharma Recent Developments
7 North America by Country
  1. 7.1 North America SPECT and PET Radiopharmaceuticals Sales by Country
  2. 7.1.1 North America SPECT and PET Radiopharmaceuticals Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America SPECT and PET Radiopharmaceuticals Sales by Country (2021-2026)
  4. 7.1.3 North America SPECT and PET Radiopharmaceuticals Sales Forecast by Country (2027-2032)
  5. 7.2 North America SPECT and PET Radiopharmaceuticals Market Size by Country
  6. 7.2.1 North America SPECT and PET Radiopharmaceuticals Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America SPECT and PET Radiopharmaceuticals Market Size by Country (2021-2026)
  8. 7.2.3 North America SPECT and PET Radiopharmaceuticals Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe SPECT and PET Radiopharmaceuticals Sales by Country
  2. 8.1.1 Europe SPECT and PET Radiopharmaceuticals Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe SPECT and PET Radiopharmaceuticals Sales by Country (2021-2026)
  4. 8.1.3 Europe SPECT and PET Radiopharmaceuticals Sales Forecast by Country (2027-2032)
  5. 8.2 Europe SPECT and PET Radiopharmaceuticals Market Size by Country
  6. 8.2.1 Europe SPECT and PET Radiopharmaceuticals Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe SPECT and PET Radiopharmaceuticals Market Size by Country (2021-2026)
  8. 8.2.3 Europe SPECT and PET Radiopharmaceuticals Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific SPECT and PET Radiopharmaceuticals Sales by Country
  2. 9.1.1 Asia-Pacific SPECT and PET Radiopharmaceuticals Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific SPECT and PET Radiopharmaceuticals Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific SPECT and PET Radiopharmaceuticals Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific SPECT and PET Radiopharmaceuticals Market Size by Country
  6. 9.2.1 Asia-Pacific SPECT and PET Radiopharmaceuticals Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific SPECT and PET Radiopharmaceuticals Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific SPECT and PET Radiopharmaceuticals Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America SPECT and PET Radiopharmaceuticals Sales by Country
  2. 10.1.1 South America SPECT and PET Radiopharmaceuticals Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America SPECT and PET Radiopharmaceuticals Sales by Country (2021-2026)
  4. 10.1.3 South America SPECT and PET Radiopharmaceuticals Sales Forecast by Country (2027-2032)
  5. 10.2 South America SPECT and PET Radiopharmaceuticals Market Size by Country
  6. 10.2.1 South America SPECT and PET Radiopharmaceuticals Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America SPECT and PET Radiopharmaceuticals Market Size by Country (2021-2026)
  8. 10.2.3 South America SPECT and PET Radiopharmaceuticals Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa SPECT and PET Radiopharmaceuticals Sales by Country
  2. 11.1.1 Middle East and Africa SPECT and PET Radiopharmaceuticals Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa SPECT and PET Radiopharmaceuticals Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa SPECT and PET Radiopharmaceuticals Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa SPECT and PET Radiopharmaceuticals Market Size by Country
  6. 11.2.1 Middle East and Africa SPECT and PET Radiopharmaceuticals Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa SPECT and PET Radiopharmaceuticals Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa SPECT and PET Radiopharmaceuticals Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 SPECT and PET Radiopharmaceuticals Value Chain Analysis
  2. 12.1.1 SPECT and PET Radiopharmaceuticals Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 SPECT and PET Radiopharmaceuticals Production Mode & Process
  7. 12.2 SPECT and PET Radiopharmaceuticals Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 SPECT and PET Radiopharmaceuticals Distributors
  10. 12.2.3 SPECT and PET Radiopharmaceuticals Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst